Charles River Laboratories | CRL - 销售和管理费用

股票价格
169.80
每天变化
2.06 1.23%
每月一次
2.36%
每年
48.09%
Q2 预测
166.17


金融业
股票价格
USD
资产
USD 7.14B
现金及等价物
USD 213.77M
销售成本
USD 722.27M
流动资产
USD 1.45B
流动负债
USD 1.12B
债务
USD 2.63B
EBIT
USD 75.82M
EBITDA
USD 258.06M
员工
18.6K
EPS每股收益
USD 2.39
股本和储备
USD 3.16B
销售毛利
USD 271.96M
债务利息支出
USD 23.78M
利息收入
USD 1.1
贷款资金
USD 2.14B
市值
USD 8.75B
净收入
USD -276.56M
营业费用
USD 918.41M
营业利润
USD 75.82M
普通股股本
USD 49.22M
PE价格收益
43.58
税前利润
USD 170.03M
销售收入
USD 994.2M
销售和管理费用
USD 196.14M
股票
USD 299.1M
贸易债权人
USD 148.8M
应收帐款人
USD 1.43B


销售和管理费用 更改 日
Agilent USD 476M 48M 2025-12
Align Technology USD 441.68M 23.88M 2025-12
Bio-Rad Laboratories USD 206.8M 900K 2025-09
Bruker USD 247.2M 4.7M 2025-12
Cardinal Health USD 1.5B 43M 2025-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Cigna USD 3.19B 242M 2025-09
Concord Medical Services Hldg CNY 140.37M 36.24M 2025-06
Danaher USD 1.86B 166M 2026-03
Dentsply International USD 383M 28M 2025-12
Elevance Health USD 10.91B 309M 2025-12
Galapagos EUR 44.42M 9.87M 2025-12
Humana USD 3.36B 614M 2025-03
Illumina USD 283M 27M 2025-12
Incyte USD 390.41M 61.33M 2025-12
Intrexon USD 10.31M 41K 2024-06
IQVIA Holdings USD 468M 46M 2025-12
Laboratory Of America USD 538.6M 13.8M 2025-12
McKesson USD 2.03B 44M 2025-12
Merck EUR 1.6B 136M 2025-12
Mettler Toledo International USD 259.83M 11.43M 2025-12
Novartis USD 3.44B 128M 2025-12
Pfizer USD 4.08B 894M 2025-12
Quest Diagnostics USD 504M 0 2026-03
Revvity USD 251.73M 9.82M 2025-12
Thermo Fisher Scientific USD 1.8B 179M 2026-03
United Therapeutics USD 190.6M 38.6M 2025-12
UnitedHealth USD 15.22B 1.44B 2025-09
Veradigm USD 27.28M 5.24M 2022-12
Waters USD 240.01M 25.78M 2025-12
West Pharmaceutical Services USD 99.5M 7M 2026-03